US Compounding Inc. is recalling 1,600 mL of its Enrofloxacin+Ketoconazole+Triamcinolone (0.5%/1%/0.1%) otic medication delivered in 30 mL Pluronic syringes. The recall was initiated due to deviations from current Good Manufacturing Practice (cGMP) standards, which are the federal regulations that ensure products are made consistently and safely. Because this medication was produced outside of these quality standards, the safety, purity, and potency of the drug cannot be guaranteed. Consumers should contact their veterinarian or pharmacist immediately to discuss using an alternative treatment.
Manufacturing deviations can lead to products that are contaminated or have incorrect concentrations of active ingredients, potentially causing ineffective treatment or adverse reactions in the animals receiving the medication.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response